VivoSeq
Other

ACL Reconstruction

0

Pipeline Programs

9

Active Trials

0

Companies Involved

ACL Reconstruction is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

5/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

22

clinical trials

Completed9 · 41%
Recruiting6 · 27%
Unknown status3 · 14%
Enrolling by invitation2 · 9%
Terminated1 · 5%
Active, not recruiting1 · 5%

Trial Activity

22 trials

ACB vs no Block for Pediatric ACL Reconstruction
Recruiting··Phase 3·NCT06875427·38 enrolled
Non-Narcotic Pain Control After ACL Reconstruction
Recruiting·TThe Cleveland Clinic·Phase 3·NCT06973785·30 enrolled
IPACK on Early Pain Scores After ACL Reconstruction
Recruiting·LLoyola University·Phase 4·NCT05985629·78 enrolled
Pain Management of ACL Reconstruction
Enrolling by invitation·UUniversity of California, Davis·N/A·NCT03365908·60 enrolled
Exparel vs Block for ACL Reconstruction
Enrolling by invitation·RRothman Institute Orthopaedics·Phase 4·NCT06006624·154 enrolled
Impact of Opioid Avoidance Protocol for ACL Reconstruction
Completed··N/A·NCT06340932·32 enrolled
Are Opioids Needed After ACL Reconstruction
Completed·EEmory University·Phase 4·NCT04285853·98 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)